Kathryn Peterson
University of Utah
Appearances
DateMay 6, 2023SOCIETY: AGAPresenters
EoE-Clinic, Olten, SwitzerlandNorthwestern University - The Feinberg School of MedicineUniversity of UtahUniversity of North Carolina School of MedicineUniversity of Colorado School of Medicine- DateMay 8, 2023BACKGROUND: Tools predicting incident esophageal adenocarcinoma (EAC) and gastric cardia adenocarcinoma (GCA) that can be automated in electronic health records (EHRs) to guide screening decisions are needed…
Speakers
Presenter
University of North Carolina School of Medicine - DateMay 9, 2023Concomitant esophageal dysmotility can be present in up to 2/3 of patients with EoE and GERD. Esophageal dysmotility contribute to symptoms in these patients and can be a reason for a suboptimal response to therapy…
Presenter
Speakers
University of UtahBaylor University Medical Center and Baylor Scott and White Research InstituteBaylor University Medical Center at Dallas - DateMay 7, 2023BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…
Presenter
University of North Carolina School of MedicineSpeakers
University of UtahUniversity of North Carolina at Chapel Hill School of Medicine - DateMay 7, 2023BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…
Presenter
University of North Carolina School of MedicineSpeakers
University of UtahUniversity of North Carolina at Chapel Hill School of Medicine - DateMay 7, 2023SOCIETY: ASGE
Presenter
University of Utah 
DateMay 19, 2024LIVE STREAM SESSION The great debates on EoE will review controversial areas in EoE management relevant to both pediatric and adult patients, including whether long-term therapy is necessary for the asymptomatic patient with minimally involved EoE, whether a full four/six food elimination diet is n…Moderators
University of UtahMonroe Carell Jr. Children's Hospital at Vanderbilt- DateMay 19, 2024RATIONALE: RNA sequencing studies have previously identified impaired barrier function and the subsequent proinflammatory response as critical to the pathogenies of EoE. However, the investigation into disease initiation is often limited by the inability to capture the disease early…
Presenter
Speakers
